This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Triad National Security, LLC, University of California, Arizona State University. Active years: 2019-2023.
Company Filing History:
2 out of 307 
2 out of 15,988 
1 out of 2,154 
Years Active: 2019-2023
Title: Katherine Lovejoy: Innovator in Transdermal Drug Delivery
Introduction
Katherine Lovejoy is a prominent inventor based in Silver Spring, MD (US). She has made significant contributions to the field of transdermal drug delivery, holding 2 patents that focus on innovative compositions and methods for enhancing drug transport through the skin.
Latest Patents
Her latest patents include groundbreaking work on ionic liquids for transdermal drug delivery. The compositions and methods described in her patents are designed to be topically applied to the skin with negligible or no irritation. These compositions can direct or prevent transport through the skin and contain neat ionic liquids, optionally combined with a drug to be delivered. In preferred embodiments, these compositions increase the transdermal transport of the drug. Additionally, they can disrupt bacterial biofilms, which is particularly beneficial in treating antibiotic-resistant skin infections. The disclosed methods can be tuned and modified to treat or prevent a variety of diseases and disorders.
Career Highlights
Katherine has worked with notable organizations such as the University of California and Triad National Security, LLC. Her work has been instrumental in advancing the understanding and application of ionic liquids in medical treatments.
Collaborations
Katherine has collaborated with esteemed colleagues, including Michael Zakrewsky and Samir M Mitragotri, further enhancing her research and innovation in the field.
Conclusion
Katherine Lovejoy's contributions to transdermal drug delivery through her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to pave the way for new treatments and advancements in healthcare.